Evidence map›Paper›PMID 40365277›Full record

ArticleTheranostics2025

Comparative study of [

Haiyan Gao, Zhiwei Ma, Ziyang Zhu, Zhichuan Yang, Bo Chen, Xiaoming Wu, Vivianne Jakobsson, Yujiao Deng, Hao Wang, Wei Zhang and 1 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haiyan GaoDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Zhiwei MaDepartment of Urology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Ziyang ZhuDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Zhichuan YangDepartment of Emergency Surgery, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu 610041, China.
Bo ChenDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xiaoming WuCollege of Nuclear Science and Technology, Harbin Engineering University, Harbin 150001, China.
Vivianne JakobssonDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
Yujiao DengDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Hao WangDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Wei ZhangDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Jingjing ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) is a significant global health concern, and the early diagnosis and accurate staging of clear cell renal cell carcinoma (ccRCC) remain major challenges. [

Indexed as

Carcinoma, Renal CellFluorodeoxyglucose F18Kidney NeoplasmsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAgedEndopeptidasesFemaleFibroblast Activation Protein AlphaFluorine RadioisotopesGelatinasesHumansIntegrin alphaVbeta3MaleMembrane ProteinsMiddle AgedEndopeptidasesFibroblast Activation Protein AlphaFluorine RadioisotopesFluorodeoxyglucose F18GelatinasesIntegrin alphaVbeta3Membrane ProteinsOligopeptidesRadiopharmaceuticalsSerine Endopeptidases[18F]AlF-radiolabelingFAPI-RGDFibroblast activation proteinIntegrin αvβ3Renal cell carcinoma

Identifiers

PMID40365277
PMCPMC12068302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.